title: Chemosensitivity testing of an ovarian cancer cell line: comparison of MTT assay and [3H]-thymidine incorporation.
abstract: Chemosensitivity test has its role in cancer therapy. Using an accurate, efficient, and simple way to choose the proper chemosensitive drugs in our clinical study will help advance our work. The MTT assay is a rapid, precise, and new method to perform drug sensitivity assay. We used an ovarian cancer cell line (OC-3L-VGH) to compare the accuracy of the MTT and the [3H]-TdR incorporation assay in measuring chemosensitivity of 7 anticancer drugs. Good correlation was observed between the MTT and the [3H]-TdR assay for drug sensitivity testing (r = 0.893, P less than 0.001). Based on this study we found it may be preferable to use the MTT assay for chemosensitivity screening.
authors.affiliation: Department of Obstetrics and Gynecology, Veterans General Hospital-Taipei, R.O.C.
authors.forename: K J
authors.initials: KJ
authors.lastname: Yu
authors.forename: H T
authors.initials: HT
authors.lastname: Ng
authors.forename: K C
authors.initials: KC
authors.lastname: Chao
authors.forename: C C
authors.initials: CC
authors.lastname: Chang
authors.forename: Y Y
authors.initials: YY
authors.lastname: Kan
mesh_terms: D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000473:pathology*; D013778:Tetrazolium Salts; D013936:Thymidine / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D013778:Tetrazolium Salts; D013936:Thymidine